PAUSE Act Ill-Serves Patients

For 25 years, the 340B Drug Pricing Program has made a difference in the lives of millions of Americans. The relatively unknown program, started in 1992, reduces the cost of drugs for many hospitals and providers who serve low-income, underinsured or uninsured patients. It was simple: Drug manufacturers discounted outpatient drugs for these entities in…

Details

All Harm, No Help in 340B Cuts

Now that a U.S. District Court has postponed the hospital industry’s legal challenge to cutbacks in the 340B drug discount program, it falls to Congress to reverse the Trump administration’s egregious new rules. Believe it or not, there’s hope, since the new rules benefit no one—quite literally. Legislation reversing them has even gained bipartisan backing…

Details